This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Somatostatin Receptor

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What Somatostatin Receptors Are

Somatostatin receptors are proteins found on the surface of many types of cells in the body. They bind to a natural hormone called somatostatin, which helps control the release of other hormones. These receptors play important roles in organs like the pancreas, digestive system, and brain. In some cancers, especially neuroendocrine tumors, somatostatin receptors may be present in higher amounts than usual.

Why Somatostatin Receptors Matter in Cancer Care

Measuring somatostatin receptors in tumor tissue can help doctors diagnose certain cancers and plan treatment. For example, gastroenteropancreatic neuroendocrine tumors (GEP-NETs) often have these receptors. Some treatments, like Lutathera (lutetium Lu 177-dotatate), are designed to attach to somatostatin receptors on tumor cells and deliver targeted radiation to help control the tumor. Imaging tests, such as the octreotide scan (also called somatostatin receptor scintigraphy), use radioactive drugs that bind to these receptors to locate tumors in the body.

What Patients Might See or Hear About Somatostatin Receptors

Patients may encounter the term somatostatin receptor in medical reports, imaging results, or treatment plans related to neuroendocrine tumors. Tests like the octreotide scan or drugs like Lutathera work by targeting these receptors. Because the presence and amount of somatostatin receptors can influence diagnosis and treatment, patients might hear their care team discuss receptor testing or receptor-positive tumors. However, the term alone does not provide a full diagnosis or treatment plan.

Where Somatostatin Receptors Appear in Care

The term may appear in pathology reports describing tumor tissue, imaging reports from scans that detect receptor-positive tumors, or treatment plans involving drugs that target these receptors. It is also relevant in clinical trials studying new therapies for neuroendocrine tumors. Seeing the term in these contexts highlights the importance of asking your care team how it applies to your specific case.

What Somatostatin Receptor Does Not Automatically Mean

Finding somatostatin receptors on tumor cells does not by itself diagnose cancer or guarantee a specific treatment. Not all tumors have these receptors, and their presence varies. The term does not indicate how aggressive a tumor is or what symptoms a patient may have. It is one piece of information among many that doctors use to understand and manage cancer.

How to Use This Information Safely

This information is meant to help patients and caregivers understand what somatostatin receptors are and why they might be important. It does not replace medical advice or decisions made by your care team. If you see this term in your medical records or hear it during visits, the best next step is to ask your doctors or nurses what it means for your diagnosis, tests, or treatment options.

Next Steps for Patients and Caregivers

When somatostatin receptors come up in your care, consider asking your team questions like: What does it mean that my tumor has (or does not have) somatostatin receptors? How does this affect my treatment options? Are there specific tests or scans I need? Understanding how this term fits into your personal health story can help you feel more informed and involved in your care.

Sources

Public source information used for this glossary entry includes: